Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Strojek

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Oral Diseases|May 25, 2012
Efficacy of short-term adjunctive subantimicrobial dose doxycycline in diabetic patients--randomized studyL Gilowski, P Kondzielnik, R Wiench, et al.
Polskie Archiwum Medycyny Wewnetrznej|August 1, 1995
[Effect of health resort treatment on the circadian rhythm of follicle-stimulating hormone (FSH), lutropin (LH), and testosterone in male patients with diabetes mellitus]W Grzeszczak, D Moczulski, E Zukowska-Szczechowska, et al.
Deutsche Medizinische Wochenschrift (1946)|March 27, 2013
[Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride]K Strojek, K H Yoon, V Hruba, et al.
Acta Diabetologica|January 6, 2004
Retrospective analysis of cardiovascular outcomes in patients with type 2 diabetes mellitus after the first acute myocardial infarctionB Moejko-Pastewka, J Tatoń, J Haczyński, et al.
Diabetes, Obesity & Metabolism|June 16, 2011
Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24-week, double-blind, placebo-controlled trialK Strojek, K H Yoon, V Hruba, et al.
Polskie Archiwum Medycyny Wewnetrznej|September 1, 1995
[Does an association between angiotensin I converting enzyme gene polymorphism and the prevalence of diabetic nephropathy in patients with diabetes type II exist?]K Strojek, W Grzeszczak, H Rudzki, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 29, 1998
A polymorphism in the gene for the atrial natriuretic peptide and diabetic nephropathy. Diabetic Nephropathy Study GroupS Schmidt, M Blüthner, R Giessel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 1, 1996
Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy. The Diabetic Nephropathy Study GroupS Schmidt, R Giessel, K H Bergis, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|February 9, 2007
Charcot's joint of the wrist in type 2 diabetes mellitusM Wróbel, A Szymborska-Kajanek, M Skiba, et al.
Diabetes & Metabolism|January 27, 2005
Initiating oral glucose-lowering therapy with metformin in type 2 diabetic patients: an evidence-based strategy to reduce the burden of late-developing diabetes complicationsA Consoli, R Gomis, S Halimi, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Oral Diseases|May 25, 2012
Efficacy of short-term adjunctive subantimicrobial dose doxycycline in diabetic patients--randomized studyL Gilowski, P Kondzielnik, R Wiench, et al.
Polskie Archiwum Medycyny Wewnetrznej|August 1, 1995
[Effect of health resort treatment on the circadian rhythm of follicle-stimulating hormone (FSH), lutropin (LH), and testosterone in male patients with diabetes mellitus]W Grzeszczak, D Moczulski, E Zukowska-Szczechowska, et al.
Deutsche Medizinische Wochenschrift (1946)|March 27, 2013
[Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride]K Strojek, K H Yoon, V Hruba, et al.
Acta Diabetologica|January 6, 2004
Retrospective analysis of cardiovascular outcomes in patients with type 2 diabetes mellitus after the first acute myocardial infarctionB Moejko-Pastewka, J Tatoń, J Haczyński, et al.
Diabetes, Obesity & Metabolism|June 16, 2011
Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24-week, double-blind, placebo-controlled trialK Strojek, K H Yoon, V Hruba, et al.
Polskie Archiwum Medycyny Wewnetrznej|September 1, 1995
[Does an association between angiotensin I converting enzyme gene polymorphism and the prevalence of diabetic nephropathy in patients with diabetes type II exist?]K Strojek, W Grzeszczak, H Rudzki, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 29, 1998
A polymorphism in the gene for the atrial natriuretic peptide and diabetic nephropathy. Diabetic Nephropathy Study GroupS Schmidt, M Blüthner, R Giessel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 1, 1996
Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy. The Diabetic Nephropathy Study GroupS Schmidt, R Giessel, K H Bergis, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|February 9, 2007
Charcot's joint of the wrist in type 2 diabetes mellitusM Wróbel, A Szymborska-Kajanek, M Skiba, et al.
Diabetes & Metabolism|January 27, 2005
Initiating oral glucose-lowering therapy with metformin in type 2 diabetic patients: an evidence-based strategy to reduce the burden of late-developing diabetes complicationsA Consoli, R Gomis, S Halimi, et al.
Pageof 6